[Federal Register Volume 79, Number 223 (Wednesday, November 19, 2014)]
[Notices]
[Pages 68885-68886]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-27351]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-15-14ARJ]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to <a href="/cdn-cgi/l/email-protection#147b7976547770773a737b62"><span class="__cf_email__" data-cfemail="650a0807250601064b020a13">[email protected]</span></a>. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Clinic Context Matters Study--New--National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control 
and Prevention (CDC).

Background and Brief Description

    The daily use of specific antiretroviral medications by persons 
without HIV infection, but at high risk of sexual or injection exposure 
to HIV, has been shown to be a safe and effective HIV prevention 
method. The Food and Drug Administration approved the use of 
Truvada[supreg] for preexposure prophylaxis PrEP) in July 2012 and CDC 
has issued Public Health Service clinical practice guidelines for its 
use.
    Because approximately 50,000 new HIV infections continue to occur 
in the U.S. each year, with rates of HIV infection increasing most 
rapidly for young MSM and because severe disparities in HIV infection 
continue among African-American men and women, incorporation of PrEP 
into HIV prevention is important. However, as a prevention tool in very 
early stages of introduction and use, there is much we need to learn 
about how to implement PrEP in real-world settings.
    CDC is requesting OMB approval to collect data over a 3-year period 
that will be used to conduct research among clinicians about their 
knowledge, attitudes, and practices related to a new intervention 
(PrEP) over the period of its initial introduction in their clinics. 
The knowledge gained will be used to refine measurement instruments and 
methods (for example, identify modifications to questions in the 
current surveys that are unclear to participants), develop training and 
educational resources and tools for use by CDC/DHAP (Division of HIV/
AIDS Prevention)-funded partners, and other organizations supporting 
delivery of PrEP in clinical settings. The project will be conducted in 
clinics in each of four cities (Houston, Newark, Chicago, and 
Philadelphia) where PrEP has recently become available at local 
community health centers. Once per year for 3 years, CDC will conduct 
an online survey of clinicians at participating clinics to collect data 
on the demographics of the respondents and their knowledge, attitudes, 
practices, and organizational factors related to PrEP and its delivery 
in their clinics. Surveys will be administered through an online survey 
Web site.
    There are no costs to respondents other than their time. The total 
annual burden hours are 88.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                   Number of
         Type of respondent                  Form name            Number of      responses per    Average hours
                                                                 respondents       respondent      per response
----------------------------------------------------------------------------------------------------------------
Clinician...........................  Clinician Consent and               175                1            30/60
                                       Interview.
----------------------------------------------------------------------------------------------------------------



[[Page 68886]]

Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-27351 Filed 11-18-14; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>